BOLD
Boundless Bio·NASDAQ
--
--(--)
--
--(--)
BOLD fundamentals
Boundless Bio (BOLD) released its earnings on Aug 5, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.7 (YoY +9.09%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.7
+9.09%
Report date
Aug 5, 2025
Earnings Call
7:00 AM on Aug 5, 2025
Meeting link.EPS
Actual | -0.77 | -0.71 | -0.7 |
Forecast | -0.8 | -0.735 | -0.65 |
Surprise | +3.75% | +3.40% | -7.69% |
Revenue
Actual | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Boundless Bio's revenue and profit?What is the revenue and EPS growth rate for Boundless Bio year over year?What is Boundless Bio's gross profit margin?What were the key takeaways from Boundless Bio’s earnings call?What guidance did Boundless Bio's management provide for the next earnings period?What is Boundless Bio's latest dividend and current dividend yield?Did Boundless Bio beat or miss consensus estimates last quarter?What does Boundless Bio do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
